Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China · Delayed Price · Currency is CNY 24.39
+0.40 (1.67%)
Mar 27, 2026, 4:00 PM EDT
SHA:688739 Market Cap
SHA:688739 has a market cap or net worth of 10.03 billion as of March 27, 2026. Its market cap has decreased by -14.14% in one year.
Market Cap
10.03B
Enterprise Value
4.97B
Revenue
1.39B
Ranking
n/a
PE Ratio
73.91
Stock Price
24.39
Market Cap Chart
Since October 28, 2021, SHA:688739's market cap has decreased from 33.32B to 10.03B, a decrease of -69.89%. That is a compound annual growth rate of -23.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 10.03B | -5.32% |
| Dec 31, 2025 | 10.59B | -0.17% |
| Dec 31, 2024 | 10.61B | -21.62% |
| Dec 29, 2023 | 13.54B | 6.87% |
| Dec 30, 2022 | 12.67B | -60.04% |
| Dec 31, 2021 | 31.70B | -4.84% |
| Oct 28, 2021 | 33.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Easton Biopharmaceuticals | 11.57B |
| Hualan Biological Vaccine | 11.41B |
| Aurisco Pharmaceutical | 10.84B |
| InventisBio | 10.36B |
| Jiangxi Fushine Pharmaceutical | 10.28B |
| HitGen | 9.94B |
| Beijing Hotgen Biotech | 9.78B |
| Chongqing Genrix Biopharmaceutical | 9.57B |